Mumbai (Maharashtra) [India], August 29 (ANI/PRNewswire): Realizing the financial burden in IVF treatment as a concern for aspiring parents, Bharat Serums and Vaccines (BSV) launched a program BSVwithU to support couples to realize their dream of parenthood. Under this initiative, BSVwithU facilitates interest-free loans and free counselling to aspiring parents considering IVF treatments. Their services are available across 100 centers in India.

Hyderabad (Telangana) [India], April 12 (ANI): Biopharmaceutical firm Bharat Serums and Vaccines Limited (BSV) on Tuesday said it would invest Rs 200 crore in the development of injectable and vaccine manufacturing facility at Genome Valley, India's first organised cluster for Life Sciences R&D and clean manufacturing activities.

Mumbai (Maharashtra) [India], March 25 (ANI/BusinessWire India): Veeva Systems (NYSE: VEEV) today announced one of India's fastest-growing biopharma companies, Bharat Serums and Vaccines Limited (BSV), is standardizing on Veeva Vault PromoMats to accelerate its end-to-end content lifecycle for scientific and promotional materials. BSV is adopting a scalable digital content platform for streamlined approvals and better content reuse to future-proof its operations in preparation for expansion into global markets.

MUMBAI India Nov 22 2021 PRNewswire -- Post-Partum Haemorrhage PPH is the leading cause of maternal death worldwide with an estimated mortality of 140 000 per year In India PPH contributed to 38 of all maternal deaths Many of these deaths occur within 4 hours of delivery which indicates that they are a consequence of the third stage of labour FOGSI acknowledges the magnitude of the problem of maternal mortality and morbidity due to PPH and has a central role to play in improving the capacity of its members through safe effective feasible and sustainable strategies and advanced medications to prevent PPH and reduce maternal deaths Post-Partum Haemorrhage PPH occurs when a woman has heavy bleeding after giving birth It is a serious condition and can put the woman at risk if the blood loss it is not quickly controlled leading to multiple complications It may happen within 1 hour of giving birth which can last up to 12 weeks post childbirth The launch event of Post-Partum Haemorrhage of Carbetocin in Mumbai began with a talk by Prof S Shantha Kumari - FOGSI president followed by a panel discussion encompassing experts like Dr Basab Mukherjee Vice President FOGSI Dr Madhuri Patel Secretary General FOGSI and Dr Archana Verma Vice President FOGSI and was moderated by Dr Bhaskar Pal Chair AICC RCOG This event was extended to 40 Gynaecologists across India wherein the discussion addressing the PPH concern in India its criticality and why new medications molecules like Carbetocin in its prevention were discussed Carbetocin is a long acting Uterotonic used to prevent Post-Partum Haemorrhage PPH after all births and is a synthetic oxytocin analogue It has a half-life of 40 minutes around 4-10 times longer than oxytocin which means it is long acting Prof SShantha Kumari - FOGSI president was the speaker during the event and shared her views on the criticality of PPH She went on to say We dont want any woman to die of PPH as we know that PPH is one of the killer diseases Post an intensive scientific discussion on Carbetocin she also mentioned We need to look at how this molecule is going to help our women and if it is going to save lives if yes then it would be a gift which we could give our womenpatients as doctors She also mentioned Our country is so huge and the number of women who are delivering is to the tune of 25-30 million per month so imagine the number of women that would need to be treated for PPH Hence she appreciated that more companies deliver Carbetocin to women which would increase the access to better medication and enable doctors to save more lives PPH is a critical condition to manage and most of the Gynaecologists Obstetricians mentioned that it can put their patients at great risk Concluding the meeting the moderator Dr Bhaskar Pal AICC RCOG also added In order to save lives from Post-Partum Haemorrhage PPH we would also need to work towards anaemia free India we need preparedness by PPH drills early action in terms of estimating the blood loss and optimising the golden hour for its treatment FOGSI Guidelinespdf Data on file About BSV Bharat Serums and Vaccines Ltd is one of the fastest growing bio-pharmaceutical companies In India For over 50 years now BSV has used its scientific resources to develop a range of biological biotech and pharmaceutical products to treat various types of diseases in womens health especially in gynaecology and critical care space and continues to contribute to preserve protect and enhance the quality of life BSV has been consistent in its efforts to raise public awareness on issues pertaining to womens health Photo httpsmmaprnewswirecommedia1693765BSVjpg PWR PWR

Mumbai (Maharashtra) [India], November 22 (ANI/PRNewswire): Post-Partum Haemorrhage (PPH) is the leading cause of maternal death worldwide, with an estimated mortality of 140 000 per year.

Mumbai (Maharashtra) [India], October 6 (ANI/PRNewswire): BSV, during the PCOS awareness month, has launched an awareness via its microsite 'Start Your Joy' talking about various aspects of PCOS.